Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Evolutionary Dynamics of Malignancy

The Genetic and Environmental Causes of Cancer - Book w. online files / update
BuchGebunden
269 Seiten
Englisch
Springererschienen am25.06.20232023
For the most hard-to-treat tumours, future progress will require molecular diagnostics to detect cancer-causing mutations in healthy subjects, and new drugs or vaccines that prevent the progression process.Chapters of this book deal with the signalling pathways that control cell division, and changes in these pathways in cancer cells.mehr
Verfügbare Formate
BuchGebunden
EUR171,19
BuchKartoniert, Paperback
EUR171,19
E-BookPDF1 - PDF WatermarkE-Book
EUR160,49

Produkt

KlappentextFor the most hard-to-treat tumours, future progress will require molecular diagnostics to detect cancer-causing mutations in healthy subjects, and new drugs or vaccines that prevent the progression process.Chapters of this book deal with the signalling pathways that control cell division, and changes in these pathways in cancer cells.
Details
ISBN/GTIN978-3-031-32572-4
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2023
Erscheinungsdatum25.06.2023
Auflage2023
Seiten269 Seiten
SpracheEnglisch
IllustrationenXIV, 269 p. 96 illus., 58 illus. in color. With online files/update.
Artikel-Nr.52228169
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Chapter 1: Cancer as a Disease of Cell Proliferation.- Chapter 2: Genetic and Chromosomal Instability.- Chapter 3:Cancer as a Disease of Defective Cell Cycle Checkpoint Function.- Chapter 4: The DNA Damage Checkpoint.- Chapter 5:Dynamics of the Spindle Assembly Checkpoint.- Chapter 6: Cancer as a Disease of Complexity: The Dynamics of Drug Resistance.- Chapter 7: Chronic Myeloid Leukaemia: a One-Hit Malignancy.- Chapter 8: Chronic Myelomonocytic Leukaemia: a Three-Hit Malignancy.- Chapter 9: The Cancer Stem Cell and Tumour Progression.- Chapter 10: Evading the antitumour immune response.- Chapter 11: Implications of Evolutionary Dynamics for Cancer Treatment and Prevention.- Chapter 12: In science, all conclusions are provisional.mehr

Schlagworte

Autor

Robert C. Jackson provides consulting services in pharmacodynamics and biomathematics. After academic positions at Yale, London, and Indiana Universities he worked in the pharmaceutical and biotechnology industries. Post-retirement volunteer positions have included Chairman of the Discovery Committee and Vice-Chair of the Clinical and Translational Research Committee for the charity, Cancer Research UK. He is author of three previous books and author or co-author of over 150 research papers which have received over 5,000 citations. Recent publications include work on evolutionary biology and on the evolutionary dynamics of leukaemias.